Bioclinica Regulatory Affairs Services provides assistance throughout the development, approval, and post-approval stages of a product's lifecycle. Our team have extensive experience helping companies achieve the necessary preparation and compliance as required by the FDA, EMEA and other global regulatory bodies. Solutions are customized to suit each client; ranging from supplementary support to a client's existing team through to a complete outsourced regulatory affairs function.
Leader in Clinical Trial
Management Solutions
Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.
Quick Links:
Language:
RT @MdFacep: FDA approvals: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer. BIG!
https://t.co/LgCzL1mvaF
@Reu…
RT @FDA_Drug_Info: National Prescription Drug Take Back Day is April 27, 2019 from 10:00 AM to 2:00 PM. Learn how to dispose of unused and…
RT @iofbonehealth: #Osteoporosis Int: Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international…
RT @HINJ_ORG: New Jersey's biopharmaceutical industry: CIANJ has assembled a panel of industry leaders @Celgene, @Bayer & @PhRMA to discuss…
RT @PhRMA: Last year, the top 15 largest biopharmaceutical companies spent more than $100 billion on R&D, according to @IQVIA_global. More…
RT @SCDM_DataDriven: Registrations for the SCDM 2019 Annual Conference are now open!! #SCDM2019
Register now for the biggest event in the…
Latest Blogs:
